When protein stability drives tumor progression
Central European Journal of Immunology · 16.05.2026 · 51 (1) · 1-2
DOI: 10.5114/ceji/221492 ↗Kurz gefasst
Editorial in der Zeitschrift Central European Journal of Immunology, online erschienen am 16.05.2026. Verfasst von Jacek Tabarkiewicz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Immunology, Faculty of Medicine, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Human Immunology, Faculty of Medicine, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland.
- Institute of Biology, University of Szczecin, Szczecin, Poland.
- Center for Experimental Immunology and Immunobiology in Infectious Diseases and Cancer, University of Szczecin, Szczecin, Poland.
- Centre of Regenerative Medicine, Medical University of Bialystok, Bialystok, Poland.
- Tissue and Cell Bank, Medical University of Bialystok Clinical Hospital, Bialystok, Poland.
Zitieren
APA
Tabarkiewicz, J., Niedźwiedzka-Rystwej, P., Tynecka, M., & Eljaszewicz, A. (2026). When protein stability drives tumor progression. Central European Journal of Immunology, 51(1), 1-2. https://doi.org/10.5114/ceji/221492
Vancouver
Tabarkiewicz J, Niedźwiedzka-Rystwej P, Tynecka M, Eljaszewicz A. When protein stability drives tumor progression. Central European Journal of Immunology. 2026;51(1):1-2. doi:10.5114/ceji/221492
BibTeX
@article{Tabarkiewicz2026,
author = {Tabarkiewicz, Jacek and Niedźwiedzka-Rystwej, Paulina and Tynecka, Marlena and Eljaszewicz, Andrzej},
title = {When protein stability drives tumor progression},
journal = {Central European Journal of Immunology},
year = {2026},
volume = {51},
number = {1},
pages = {1--2},
doi = {10.5114/ceji/221492}
}
EUVIMED